Dichrocephala integrifolia
Dichrocephala integrifolia · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Dichrocephala integrifolia is a botanical species recognized for its diverse range of pharmacological potential. Scientific investigations into this plant have specifically focused on the therapeutic activities of its leaves. Researchers have utilized various preparations, including aqueous, ethanolic, and methanolic extracts, to study its chemical properties. Furthermore, specialized studies have employed dichloromethane fractions to isolate specific bioactive compounds. These concentrated extracts have demonstrated significant anthelmintic properties, highlighting the plant's value in combating parasitic infections.
- Synonyms
- Ethulia Integrifolia · Hippia Integrifolia
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Dichrocephala integrifolia is a botanical species known by a diverse array of regional and linguistic names. It is frequently referred to by the common name Auriculate Dichrocephala or simply as Seprah in certain areas. In different linguistic contexts, you may encounter it called dvojfarbenka celistvolistá or the Chinese designation yu yan cao. The plant is also identified in Cyrillic script as Дихроцефала цельнолистная. These varying monikers reflect the broad geographical reach and cultural variety associated with this unique plant.
Sources: Catalogue of Life (COL)
Synonyms
Dichrocephala integrifolia is a botanical species that is frequently identified through various taxonomic names. Due to historical classification shifts, it is widely recognized by its synonym, Ethulia integrifolia. Researchers and botanists may also encounter this plant listed under the name Hippia integrifolia in older literature. These varying designations highlight the complex nature of plant nomenclature and the evolving history of botanical study. Understanding these synonymous relationships is essential for ensuring accuracy when documenting the species in scientific records.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Dichrocephala integrifolia is a distinctive member of the kingdom Plantae. Within this vast biological realm, it belongs to the class Equisetopsida. The plant is further classified under the order Asterales, showcasing its evolutionary connections. It sits firmly within the family Asteraceae, a group known for its diverse floral structures. Ultimately, its scientific identity is defined by its placement in the genus Dichrocephala.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Dichrocephala |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Dichrocephala integrifolia is a plant species primarily concentrated within the diverse landscapes of the African continent. Its natural distribution spans across East Tropical Africa, where it can be found in Kenya, Tanzania, and Uganda. Additionally, the species extends its reach into the Northeast Tropical Africa region. Within this northern expanse, it is specifically documented in the territories of Eritrea and Ethiopia. This wide geographic range highlights the plant's adaptability to various tropical environments across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Dichrocephala integrifolia is a self-supporting herb that maintains a sturdy structure as it grows. This plant exhibits a versatile size range, with heights typically starting as low as 0.1 m. As it matures, many specimens reach a minimum height of 1 m. However, the growth can extend even further, reaching a maximum height of 1.5 m. This variation in stature allows the species to adapt effectively to its specific environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Dichrocephala integrifolia has demonstrated significant anthelmintic activity through recent scientific evaluation. In a study focused on the medicinal plants of Nepal, extracts of this species were shown to significantly reduce the motility of the nematode Caenorhabditis elegans. This particular biological effect was found to be comparable in efficacy to the known anthelmintic drug levamisole. Such findings highlight the plant's potential as a natural source of treatments for parasitic infections. Ultimately, identifying these properties in local flora supports essential bioprospecting efforts to develop new drug options in regions facing high disease burdens.
Compounds
Conditions
Dichrocephala integrifolia demonstrates significant medicinal potential by reducing the motility of C. elegans. This plant also exhibits inhibitory effects against CTX-M-14 through specific phytocompound interactions. Furthermore, its extracts show synergistic activity against CTX-M-producing organisms. In animal models, Dichrocephala integrifolia treats Salmonella typhi-infected rats by providing antioxidant protection and reducing tissue damage. Additionally, the plant has been shown to inhibit the growth of all tested cancer cell lines.
Preparations
Dichrocephala integrifolia is prepared as ethanolic and methanolic extracts to study its diverse medicinal properties. It is also prepared as aqueous and ethanolic extracts to evaluate its efficacy against gastro-intestinal nematode parasites. Furthermore, the plant is prepared as a dichloromethane fraction to investigate its antioxidant activity in subjects infected with Salmonella typhi. Research also utilizes Dichrocephala integrifolia prepared as an extract to identify synergistic potential against antibiotic-resistant organisms. Finally, the plant is prepared as methanolic and aqueous extracts to test its antiproliferative and antimicrobial capabilities against various cell lines and bacteria.
Parts used
Dichrocephala integrifolia is a medicinal plant belonging to the Asteraceae family that has demonstrated significant potential in treating gastrointestinal parasites. Research specifically focused on the plant's leaf, utilizing both aqueous and ethanolic extracts to test their efficacy against the nematode Heligmosomoides bakeri. While the aqueous extracts showed only weak activity, the ethanolic extracts proved highly effective at specific concentrations. These leaf extracts successfully inhibited egg embryonation and hatching while inducing high mortality rates in both L1 and L2 larval stages. Such findings suggest that the bioactive compounds found within the leaves possess potent ovicidal and larvicidal properties.